🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 10 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/04/1998 | 58,62 | 58,86 | 57,91 | 58,33 | +1,56% | 1,63% | 7.150.504 |
| 17/04/1998 | 56,77 | 57,67 | 56,00 | 57,43 | +0,78% | 2,94% | 10.287.378 |
| 16/04/1998 | 57,73 | 57,82 | 56,18 | 56,98 | -3,29% | 2,84% | 12.048.437 |
| 15/04/1998 | 59,64 | 59,82 | 57,76 | 58,92 | -1,20% | 3,45% | 6.416.066 |
| 14/04/1998 | 60,11 | 60,26 | 59,19 | 59,64 | -0,20% | 1,79% | 3.977.160 |
| 13/04/1998 | 60,23 | 60,47 | 59,01 | 59,76 | -0,79% | 2,43% | 6.729.837 |
| 09/04/1998 | 61,01 | 61,31 | 59,94 | 60,23 | -1,22% | 2,25% | 5.263.685 |
| 08/04/1998 | 62,50 | 62,74 | 60,59 | 60,98 | -2,25% | 3,44% | 5.991.206 |
| 07/04/1998 | 62,68 | 62,86 | 61,81 | 62,38 | -0,90% | 1,66% | 3.127.651 |
| 06/04/1998 | 63,45 | 63,45 | 62,77 | 62,95 | +0,38% | 1,08% | 3.535.952 |
| 03/04/1998 | 63,19 | 63,33 | 62,44 | 62,71 | -0,71% | 1,42% | 4.551.674 |
| 02/04/1998 | 62,44 | 63,25 | 61,90 | 63,16 | +1,92% | 2,15% | 5.127.026 |
| 01/04/1998 | 61,25 | 62,02 | 60,47 | 61,96 | +1,32% | 2,53% | 5.588.984 |
| 31/03/1998 | 60,83 | 61,67 | 60,77 | 61,16 | +1,53% | 1,47% | 3.946.768 |
| 30/03/1998 | 60,71 | 61,13 | 60,23 | 60,23 | -1,17% | 1,47% | 3.487.744 |
| 27/03/1998 | 61,67 | 62,23 | 60,47 | 60,95 | -0,58% | 2,85% | 6.133.315 |
| 26/03/1998 | 62,02 | 62,44 | 60,95 | 61,31 | -1,15% | 2,40% | 4.406.630 |
| 25/03/1998 | 62,89 | 62,92 | 60,65 | 62,02 | -1,42% | 3,60% | 5.052.618 |
| 24/03/1998 | 63,22 | 63,36 | 62,53 | 62,92 | +0,62% | 1,32% | 3.119.058 |
| 23/03/1998 | 62,74 | 63,07 | 61,93 | 62,53 | -0,62% | 1,81% | 4.317.550 |
| 20/03/1998 | 62,65 | 62,95 | 62,08 | 62,92 | +0,67% | 1,38% | 5.452.534 |
| 19/03/1998 | 62,74 | 63,07 | 61,90 | 62,50 | -0,38% | 1,85% | 2.889.965 |
| 18/03/1998 | 62,98 | 63,04 | 62,38 | 62,74 | -0,47% | 1,04% | 3.041.506 |
| 17/03/1998 | 61,81 | 63,16 | 61,67 | 63,04 | +2,03% | 2,41% | 4.448.550 |
| 16/03/1998 | 61,19 | 61,87 | 60,92 | 61,78 | +0,97% | 1,56% | 3.236.224 |
| 13/03/1998 | 62,20 | 62,29 | 60,89 | 61,19 | -0,63% | 2,25% | 3.324.046 |
| 12/03/1998 | 61,55 | 61,84 | 61,01 | 61,58 | -0,53% | 1,36% | 3.240.416 |
| 11/03/1998 | 62,29 | 62,50 | 61,87 | 61,90 | -0,81% | 1,01% | 2.880.533 |
| 10/03/1998 | 61,40 | 62,47 | 61,40 | 62,41 | +1,65% | 1,75% | 4.829.603 |
| 09/03/1998 | 60,89 | 61,52 | 60,71 | 61,40 | +1,03% | 1,32% | 3.894.787 |